The present study focused on examining the effects of the GGTase I inhibitor GGTI-298, as well as GGTI-DU40, on induction of apoptosis, particularly induced by TRAIL, in human non-small cell lung cancer (NSCLC) cells and on understanding underlying mechanisms. Here, PGGT1B is linked to non-small cell lung carcinoma.